SANDRA DEGROAT: Open Payments
NPI 1144625799 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 25 payments from 7 companies in 2025. Trend: 2023 $463 · 2024 $657 · 2025 $1,471
Food & beverage: $1,471
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $420 |
| E.R. Squibb & Sons, L.L.C. | 6 | $346 |
| Alkermes, Inc. | 3 | $236 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $236 |
| Braeburn Inc. | 1 | $110 |
| Teva Pharmaceuticals USA, Inc. | 5 | $108 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: INVEGA SUSTENNA, COBENFY, CAPLYTA, LYBALVI, ARISTADA, BRIXADI, AUSTEDO XR, UZEDY.
Industry payments across AZ — which companies pay providers there.
